OXYMETAZOLINE HYDROCHLORIDE OPHTHALMIC

OXYMETAZOLINE HYDROCHLORIDE OPHTHALMIC was reported 2364 times

OXYMETAZOLINE HYDROCHLORIDE OPHTHALMIC is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 MESENTERIC CYST 1 0.0769
1 CORNEAL LACERATION 1 0.0556
2 BILIARY HAMARTOMA 1 0.0526
3 IRIS DISCOLOURATION 2 0.0435
4 GIANT PAPILLARY CONJUNCTIVITIS 2 0.0400
5 TEAR DISCOLOURATION 1 0.0222
6 EYELASH INJURY 1 0.0200
7 EYELID RETRACTION 2 0.0200
8 BENIGN NEOPLASM OF EYE 1 0.0200
9 EYELID FUNCTION DISORDER 15 0.0190
10 ARCUS LIPOIDES 1 0.0159
11 CONJUNCTIVAL CYST 1 0.0156
12 DEAFNESS PERMANENT 3 0.0153
13 EYELID DISORDER 33 0.0143
14 SWELLING OF EYELID 88 0.0140
15 VASCULAR CAUTERISATION 1 0.0132
16 CORNEAL IRRITATION 1 0.0125
17 SCLERAL OEDEMA 1 0.0120
18 EYELID CYST 3 0.0116
19 MANDIBULAR MASS 1 0.0114
20 VITAMIN K DECREASED 1 0.0106
21 VITREORETINAL TRACTION SYNDROME 1 0.0105
22 EYELID PAIN 21 0.0103
23 EYELID SENSORY DISORDER 2 0.0102
24 MYDRIASIS 130 0.0101
25 EAR LOBE INFECTION 1 0.0098
26 PERIORBITAL PAIN 8 0.0094
27 SWOLLEN TEAR DUCT 1 0.0094
28 EYELID IRRITATION 23 0.0092
29 HYPERTROPHY OF TONGUE PAPILLAE 1 0.0083
30 CONJUNCTIVAL DISCOLOURATION 1 0.0082
31 INFUSION SITE SCAB 1 0.0081
32 ANTI-THYROID ANTIBODY INCREASED 1 0.0079
33 AUTOIMMUNE NEUROPATHY 1 0.0078
34 QUADRANTANOPIA 1 0.0076
35 INSTILLATION SITE DISCOMFORT 1 0.0075
36 DEVICE COLOUR ISSUE 3 0.0074
37 EPIRETINAL MEMBRANE 2 0.0072
38 INSTILLATION SITE FOREIGN BODY SENSATION 1 0.0069
39 MULTIPLE USE OF SINGLE-USE PRODUCT 38 0.0068
40 THERAPEUTIC PRODUCT EFFECT PROLONGED 3 0.0066
41 ABNORMAL SENSATION IN EYE 28 0.0065
42 ERYTHEMA OF EYELID 35 0.0065
43 CONTACT LENS INTOLERANCE 1 0.0064
44 NONINFECTIVE SIALOADENITIS 1 0.0063
45 CHALAZION 4 0.0062
46 SCLERAL DISCOLOURATION 4 0.0061
47 VITREOUS DEGENERATION 1 0.0061
48 DOSING ERROR 1 0.0060
49 EYELID INJURY 1 0.0057
50 EYELASH CHANGES 1 0.0056
51 FOREIGN BODY SENSATION IN EYES 35 0.0055
52 OCULAR HYPERAEMIA 257 0.0054
53 CORNEAL REFLEX DECREASED 2 0.0053
54 HALO VISION 6 0.0053
55 SIGHT DISABILITY 1 0.0053
56 ASTHENOPIA 28 0.0051
57 EYELID EXFOLIATION 4 0.0051
58 RETINAL ANEURYSM 1 0.0050
59 EYELID MARGIN CRUSTING 14 0.0048
60 EYE IRRITATION 276 0.0048
61 HORDEOLUM 20 0.0046
62 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 28 0.0045
63 BLEPHARITIS 18 0.0045
64 EYELID SKIN DRYNESS 5 0.0041
65 EXCESSIVE EYE BLINKING 6 0.0041
66 OCULAR DISCOMFORT 45 0.0040
67 KERATOMILEUSIS 1 0.0039
68 INJURY CORNEAL 2 0.0038
69 DRY EYE 186 0.0037
70 EYE COMPLICATION ASSOCIATED WITH DEVICE 1 0.0037
71 PERIORBITAL SWELLING 21 0.0037
72 SCLERAL DISORDER 1 0.0037
73 BLEPHAROSPASM 23 0.0036
74 INSTILLATION SITE PAIN 9 0.0036
75 RETINAL OPERATION 1 0.0036
76 EYE PRURITUS 119 0.0035
77 HYPOAESTHESIA EYE 2 0.0034
78 EYE DISCHARGE 34 0.0033
79 EYE PAIN 183 0.0032
80 INCREASED DOSE ADMINISTERED 1 0.0032
81 PERIORAL DERMATITIS 2 0.0031
82 LACRIMATION INCREASED 90 0.0030
83 PERIORBITAL IRRITATION 1 0.0029
84 EYELIDS PRURITUS 9 0.0029
85 OPHTHALMIC MIGRAINE 2 0.0029
86 CONJUNCTIVAL HAEMORRHAGE 11 0.0029
87 GLASSY EYES 2 0.0028
88 FACIAL DISCOMFORT 2 0.0028
89 VITREOUS DETACHMENT 6 0.0028
90 MILIA 1 0.0028
91 ANISOCORIA 1 0.0026
92 THERAPEUTIC PRODUCT EFFECT INCREASED 3 0.0026
93 EYELID PTOSIS 26 0.0026
94 CORNEAL TRANSPLANT 2 0.0026
95 VISUAL BRIGHTNESS 1 0.0025
96 DRUG EFFECT LESS THAN EXPECTED 37 0.0025
97 LAGOPHTHALMOS 1 0.0024
98 TRANSFERRIN SATURATION DECREASED 1 0.0023
99 DACRYOSTENOSIS ACQUIRED 3 0.0023
100 EYELID INFECTION 1 0.0023
101 VISION BLURRED 311 0.0023
102 PUNCTATE KERATITIS 2 0.0022
103 EXTRAOCULAR MUSCLE PARESIS 1 0.0022
104 METAMORPHOPSIA 4 0.0022
105 SKIN INDENTATION 1 0.0021
106 EYELID RASH 2 0.0020
107 APPLICATION SITE ACNE 1 0.0020
108 RETINAL TEAR 5 0.0020
109 LENTIGO 1 0.0020
110 CORNEAL SCAR 1 0.0020
111 GLARE 1 0.0019
112 PHOTOPHOBIA 36 0.0019
113 EYELID OEDEMA 22 0.0019
114 EYE SWELLING 70 0.0019
115 SUPERFICIAL INJURY OF EYE 2 0.0018
116 VITREOUS FLOATERS 18 0.0018
117 EYE INFECTION BACTERIAL 1 0.0018
118 THERAPEUTIC PRODUCT EFFECT VARIABLE 6 0.0015
119 BROW PTOSIS 1 0.0015
120 CATARACT NUCLEAR 1 0.0015
121 TONGUE DRY 2 0.0015
122 MIGRAINE WITH AURA 4 0.0015
123 CORNEAL OPACITY 2 0.0015
124 CUTANEOUS SYMPTOM 1 0.0015
125 CORNEAL ABRASION 2 0.0015
126 VITREOUS HAEMORRHAGE 4 0.0014
127 INTRAOCULAR PRESSURE TEST ABNORMAL 1 0.0014
128 EXOPHTHALMOS 3 0.0014
129 EYE INFLAMMATION 13 0.0014
130 DARK CIRCLES UNDER EYES 2 0.0014
131 DRUG TOLERANCE INCREASED 1 0.0013
132 PHOTOPSIA 8 0.0013
133 GRANULOMA SKIN 1 0.0012
134 DOCUMENTED HYPERSENSITIVITY TO ADMINISTERED PRODUCT 1 0.0012
135 DYSCHROMATOPSIA 1 0.0012
136 ENDOCRINE OPHTHALMOPATHY 1 0.0012
137 EYE INFECTION 13 0.0012
138 INTESTINAL INFARCTION 1 0.0011
139 CERUMEN IMPACTION 1 0.0011
140 PARANASAL SINUS DISCOMFORT 4 0.0011
141 PRODUCT AFTER TASTE 1 0.0010
142 ANTINUCLEAR ANTIBODY INCREASED 1 0.0010
143 TELANGIECTASIA 1 0.0010
144 CONJUNCTIVAL OEDEMA 1 0.0010
145 THERAPEUTIC PRODUCT EFFECT DECREASED 43 0.0010
146 PRODUCT ADMINISTRATION ERROR 19 0.0009
147 DRY AGE-RELATED MACULAR DEGENERATION 1 0.0009
148 FACIAL SPASM 1 0.0009
149 CORNEAL OEDEMA 2 0.0009
150 PUPILS UNEQUAL 1 0.0009
151 CARBON DIOXIDE DECREASED 1 0.0009
152 CHEMICAL BURN 1 0.0009
153 APPLICATION SITE DISCHARGE 1 0.0009
154 AORTIC VALVE REPLACEMENT 1 0.0008
155 PRODUCT USED FOR UNKNOWN INDICATION 1 0.0008
156 INTESTINAL DILATATION 1 0.0007
157 MACULAR HOLE 1 0.0007
158 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 1 0.0007
159 SKIN WRINKLING 2 0.0007
160 ULCERATIVE KERATITIS 2 0.0007
161 NEOVASCULAR AGE-RELATED MACULAR DEGENERATION 1 0.0007
162 AUDITORY DISORDER 1 0.0007
163 INCORRECT DRUG ADMINISTRATION RATE 3 0.0007
164 TENSION HEADACHE 3 0.0007
165 NOROVIRUS INFECTION 1 0.0007
166 SEBORRHOEIC KERATOSIS 1 0.0007
167 GENERALISED ANXIETY DISORDER 1 0.0007
168 PRECANCEROUS SKIN LESION 1 0.0007
169 PHYSICAL DISABILITY 3 0.0007
170 APRAXIA 1 0.0007
171 EYE HAEMORRHAGE 9 0.0007
172 CATARACT OPERATION 4 0.0007
173 GASTROINTESTINAL WALL THICKENING 1 0.0007
174 HYPOSMIA 1 0.0007
175 ASTIGMATISM 1 0.0007
176 MASTICATION DISORDER 2 0.0007
177 DEVICE PHYSICAL PROPERTY ISSUE 5 0.0007
178 EYE ALLERGY 1 0.0006
179 ONYCHOLYSIS 1 0.0006
180 BACTERIAL VAGINOSIS 1 0.0006
181 SKIN TIGHTNESS 3 0.0006
182 OPHTHALMOPLEGIA 1 0.0006
183 INHIBITORY DRUG INTERACTION 1 0.0006
184 PHARYNGEAL PARAESTHESIA 1 0.0006
185 GLYCOSYLATED HAEMOGLOBIN DECREASED 1 0.0006
186 INCORRECT DOSAGE ADMINISTERED 3 0.0006
187 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 43 0.0006
188 MEAN CELL HAEMOGLOBIN INCREASED 1 0.0006
189 MADAROSIS 7 0.0006
190 VEIN RUPTURE 1 0.0006
191 ACUTE SINUSITIS 1 0.0006
192 BLOOD CHLORIDE INCREASED 1 0.0006
193 DIPLOPIA 15 0.0006
194 SPONDYLOLISTHESIS 1 0.0006
195 INFUSION SITE DISCHARGE 1 0.0006
196 CONJUNCTIVAL HYPERAEMIA 2 0.0006
197 EYE DISORDER 18 0.0005
198 RETINAL DETACHMENT 5 0.0005
199 AURA 1 0.0005
200 PRODUCT STORAGE ISSUE 2 0.0005
201 HYPOGEUSIA 1 0.0005
202 CONCOMITANT DISEASE AGGRAVATED 3 0.0005
203 CONJUNCTIVITIS 9 0.0005
204 DEVICE MATERIAL ISSUE 1 0.0005
205 INTRAOCULAR PRESSURE INCREASED 6 0.0005
206 DRUG INEFFECTIVE 618 0.0005
207 PRODUCT DISPENSING ISSUE 2 0.0005
208 FACIAL PAIN 4 0.0004
209 SINUS PAIN 1 0.0004
210 FEELING JITTERY 8 0.0004
211 URINARY HESITATION 1 0.0004
212 WRONG DOSE 1 0.0004
213 PAROSMIA 3 0.0004
214 EXPIRED PRODUCT ADMINISTERED 13 0.0004
215 MEAN CELL VOLUME INCREASED 1 0.0004
216 PRODUCT TEMPERATURE EXCURSION ISSUE 2 0.0004
217 PRODUCT PACKAGING DIFFICULT TO OPEN 1 0.0004
218 NASAL DISCOMFORT 3 0.0004
219 ADVERSE REACTION 5 0.0004
220 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 1 0.0004
221 EAR CONGESTION 1 0.0004
222 JAW DISORDER 2 0.0004
223 MACULAR OEDEMA 2 0.0004
224 STRABISMUS 1 0.0003
225 MACULAR DEGENERATION 4 0.0003
226 IRITIS 1 0.0003
227 KERATITIS 1 0.0003
228 BLOOD PRESSURE INCREASED 50 0.0003
229 BLOOD BLISTER 1 0.0003
230 IRIDOCYCLITIS 1 0.0003
231 HEADACHE 197 0.0003
232 SUBSTANCE USE DISORDER 1 0.0003
233 CARDIAC FLUTTER 2 0.0003
234 VULVOVAGINAL DRYNESS 1 0.0003
235 DEAFNESS NEUROSENSORY 1 0.0003
236 INFUSION SITE HAEMORRHAGE 1 0.0003
237 POTENTIATING DRUG INTERACTION 1 0.0003
238 DRY THROAT 3 0.0003
239 HEPATIC CYST 1 0.0003
240 RETINAL HAEMORRHAGE 2 0.0003
241 SWELLING FACE 18 0.0003
242 BLOOD PHOSPHORUS DECREASED 1 0.0003
243 FEELING DRUNK 2 0.0003
244 HYPOAESTHESIA ORAL 4 0.0003
245 CHEMOTHERAPY 1 0.0003
246 THYROID MASS 1 0.0003
247 OPTIC ISCHAEMIC NEUROPATHY 1 0.0003
248 BLOOD PRESSURE SYSTOLIC INCREASED 5 0.0003
249 MIGRAINE 24 0.0003
250 MYASTHENIA GRAVIS 2 0.0002
251 ENURESIS 1 0.0002
252 FRUSTRATION TOLERANCE DECREASED 2 0.0002
253 PERIPHERAL VENOUS DISEASE 1 0.0002
254 SENSATION OF FOREIGN BODY 2 0.0002
255 TONGUE DISCOMFORT 1 0.0002
256 POOR PERIPHERAL CIRCULATION 1 0.0002
257 FACIAL PARALYSIS 2 0.0002
258 SKIN SWELLING 2 0.0002
259 ORTHOSTATIC HYPOTENSION 4 0.0002
260 MELANOCYTIC NAEVUS 1 0.0002
261 OFF LABEL USE 199 0.0002
262 BLOOD THYROID STIMULATING HORMONE DECREASED 1 0.0002
263 BLOOD PRESSURE SYSTOLIC DECREASED 1 0.0002
264 LUMBAR VERTEBRAL FRACTURE 1 0.0002
265 VISUAL IMPAIRMENT 27 0.0002
266 SEASONAL ALLERGY 3 0.0002
267 PHARYNGEAL SWELLING 2 0.0002
268 BREATH SOUNDS ABNORMAL 1 0.0002
269 ECONOMIC PROBLEM 3 0.0002
270 EAR DISCOMFORT 2 0.0002
271 TRISMUS 1 0.0002
272 PRODUCT ODOUR ABNORMAL 2 0.0002
273 NYSTAGMUS 1 0.0002
274 PALPITATIONS 22 0.0002
275 PRODUCT RESIDUE PRESENT 1 0.0002
276 MUSCLE TIGHTNESS 3 0.0002
277 TIC 1 0.0002
278 NONSPECIFIC REACTION 1 0.0002
279 PHOTOSENSITIVITY REACTION 3 0.0002
280 HYPERKERATOSIS 1 0.0002
281 REBOUND EFFECT 2 0.0002
282 DERMATITIS CONTACT 2 0.0002
283 CORONARY ARTERY BYPASS 1 0.0002
284 HERPES VIRUS INFECTION 1 0.0002
285 RHINORRHOEA 11 0.0002
286 ENERGY INCREASED 1 0.0002
287 TYPE 1 DIABETES MELLITUS 1 0.0002
288 ACCIDENTAL OVERDOSE 6 0.0002
289 INFUSION SITE EXTRAVASATION 1 0.0002
290 SOMNAMBULISM 1 0.0002
291 DISABILITY 3 0.0002
292 PRODUCT FORMULATION ISSUE 1 0.0002
293 HEART RATE INCREASED 15 0.0002
294 SKIN MASS 1 0.0001
295 MENINGITIS 1 0.0001
296 POSTOPERATIVE WOUND INFECTION 1 0.0001
297 SINUS CONGESTION 2 0.0001
298 RESPIRATION ABNORMAL 1 0.0001
299 DEFAECATION URGENCY 1 0.0001
300 BLINDNESS UNILATERAL 2 0.0001
301 THERMAL BURN 1 0.0001
302 IMPAIRED QUALITY OF LIFE 2 0.0001
303 PARAESTHESIA ORAL 2 0.0001
304 PANIC REACTION 1 0.0001
305 VISUAL FIELD DEFECT 1 0.0001
306 RASH PRURITIC 7 0.0001
307 BRAIN FOG 2 0.0001
308 RENAL CYST 1 0.0001
309 INTENTIONAL PRODUCT MISUSE 11 0.0001
310 STENT PLACEMENT 1 0.0001
311 PRESYNCOPE 3 0.0001
312 DECUBITUS ULCER 1 0.0001
313 BLINDNESS 5 0.0001
314 UPPER-AIRWAY COUGH SYNDROME 1 0.0001
315 MENSTRUAL DISORDER 1 0.0001
316 THERAPEUTIC RESPONSE SHORTENED 4 0.0001
317 DRUG USE DISORDER 1 0.0001
318 DIZZINESS 59 0.0001
319 CATARACT 7 0.0001
320 HYPOPHAGIA 3 0.0001
321 VITAMIN D DECREASED 1 0.0001
322 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 2 0.0001
323 PRODUCT CONTAINER ISSUE 1 0.0001
324 MUSCLE STRAIN 1 0.0001
325 DEVICE USE ISSUE 2 0.0001
326 THERAPEUTIC RESPONSE UNEXPECTED 5 0.0001
327 DRY MOUTH 9 0.0001
328 LIP DRY 1 0.0001
329 SKIN DISCOLOURATION 5 0.0001
330 BLOOD THYROID STIMULATING HORMONE INCREASED 1 0.0001
331 BLOOD GLUCOSE ABNORMAL 2 0.0001
332 HYPERSENSITIVITY 20 0.0001
333 SQUAMOUS CELL CARCINOMA 1 0.0001
334 INCREASED APPETITE 2 0.0001
335 LIGAMENT SPRAIN 1 0.0001
336 TASTE DISORDER 2 0.0001
337 DISCOMFORT 6 0.0001
338 SLUGGISHNESS 1 0.0001
339 INITIAL INSOMNIA 1 0.0001
340 LIMB DISCOMFORT 3 0.0001
341 TEMPERATURE INTOLERANCE 1 0.0001
342 TENDERNESS 1 0.0001
343 INJECTION SITE DISCOMFORT 1 0.0001
344 BIPOLAR DISORDER 1 0.0001
345 SKIN LACERATION 1 0.0001
346 PRODUCT PRESCRIBING ISSUE 2 0.0001
347 OESOPHAGITIS 1 0.0001
348 NECK PAIN 5 0.0001
349 SNEEZING 2 0.0001
350 PRODUCT USE IN UNAPPROVED INDICATION 22 0.0001
351 IMPAIRED DRIVING ABILITY 1 0.0001
352 SCAB 1 0.0001
353 TINNITUS 4 0.0001
354 POST PROCEDURAL HAEMORRHAGE 1 0.0001
355 SPINAL PAIN 1 0.0001
356 NASAL CONGESTION 5 0.0001
357 HYPERLIPIDAEMIA 1 0.0001
358 BURSITIS 1 0.0001
359 FIBROMYALGIA 2 0.0001
360 VERTIGO 5 0.0001
361 TENDON RUPTURE 1 0.0001
362 DYSGEUSIA 6 0.0001
363 CYST 1 0.0001
364 SECRETION DISCHARGE 1 0.0001
365 DERMATITIS ALLERGIC 1 0.0001
366 CHEST DISCOMFORT 8 0.0001
367 ADVERSE EVENT 7 0.0001
368 ORAL CANDIDIASIS 1 0.0001
369 SARS-COV-2 TEST POSITIVE 1 0.0001
370 QUALITY OF LIFE DECREASED 1 0.0001
371 PAIN OF SKIN 2 0.0001
372 DISTURBANCE IN ATTENTION 4 0.0001
373 UVEITIS 1 0.0001
374 CORONARY ARTERY OCCLUSION 1 0.0001
375 COORDINATION ABNORMAL 1 0.0001
376 URTICARIA 12 0.0001
377 SKIN REACTION 1 0.0001
378 INTERNATIONAL NORMALISED RATIO INCREASED 2 0.0001
379 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 2 0.0001
380 TACHYCARDIA 6 0.0001
381 ADVERSE DRUG REACTION 6 0.0001
382 SKIN IRRITATION 3 0.0001
383 PRODUCT USE COMPLAINT 1 0.0001
384 PSYCHOMOTOR HYPERACTIVITY 1 0.0001
385 LIP SWELLING 2 0.0001
386 URINARY RETENTION 2 0.0001
387 PRODUCT USE ISSUE 11 0.0001
388 INTENTIONAL PRODUCT USE ISSUE 5 0.0001
389 HEAD DISCOMFORT 1 0.0001
390 RESTLESS LEGS SYNDROME 1 0.0001
391 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 3 0.0001
392 BACTERIAL INFECTION 1 0.0001
393 ERYTHEMA 11 0.0001
394 FOOT FRACTURE 1 0.0001
395 BLOOD URINE PRESENT 1 0.0001
396 SLEEP APNOEA SYNDROME 1 0.0001
397 PRESCRIBED OVERDOSE 1 0.0001
398 EAR PAIN 1 0.0001
399 PARAESTHESIA 8 0.0001
400 PRESCRIBED UNDERDOSE 1 0.0001
401 EXTRA DOSE ADMINISTERED 2 0.0000
402 INJURY ASSOCIATED WITH DEVICE 1 0.0000
403 SKIN EXFOLIATION 4 0.0000
404 RETCHING 1 0.0000
405 IMPAIRED WORK ABILITY 1 0.0000
406 POOR QUALITY SLEEP 1 0.0000
407 SKIN CANCER 1 0.0000
408 BALANCE DISORDER 4 0.0000
409 CONDITION AGGRAVATED 14 0.0000
410 INTERVERTEBRAL DISC PROTRUSION 1 0.0000
411 PRODUCT STORAGE ERROR 4 0.0000
412 APPLICATION SITE PAIN 1 0.0000
413 RASH PAPULAR 1 0.0000
414 HEART RATE IRREGULAR 1 0.0000
415 APPLICATION SITE PRURITUS 1 0.0000
416 MUSCULAR WEAKNESS 5 0.0000
417 MUSCLE TWITCHING 1 0.0000
418 INJURY 3 0.0000
419 DYSPHAGIA 4 0.0000
420 BLOOD GLUCOSE DECREASED 2 0.0000
421 EMOTIONAL DISTRESS 5 0.0000
422 MENTAL IMPAIRMENT 1 0.0000
423 NEURALGIA 1 0.0000
424 EPISTAXIS 3 0.0000
425 HOT FLUSH 3 0.0000
426 CELLULITIS 2 0.0000
427 GLYCOSYLATED HAEMOGLOBIN INCREASED 1 0.0000
428 INCORRECT DOSE ADMINISTERED 9 0.0000
429 PRURITUS 15 0.0000
430 ANAPHYLACTIC SHOCK 1 0.0000
431 NERVOUSNESS 2 0.0000
432 APPLICATION SITE ERYTHEMA 1 0.0000
433 HYPERTENSION 8 0.0000
434 INSOMNIA 10 0.0000
435 THROAT TIGHTNESS 1 0.0000
436 LIMB INJURY 1 0.0000
437 PALLOR 1 0.0000
438 PROCEDURAL PAIN 1 0.0000
439 FEELING COLD 1 0.0000
440 WOUND 1 0.0000
441 PRODUCT DOSE OMISSION IN ERROR 1 0.0000
442 PAIN IN JAW 1 0.0000
443 INTENTIONAL DOSE OMISSION 1 0.0000
444 LETHARGY 2 0.0000
445 DYSSTASIA 1 0.0000
446 DYSPHONIA 2 0.0000
447 CHILLS 4 0.0000
448 MALAISE 14 0.0000
449 ANXIETY 9 0.0000
450 HEAD INJURY 1 0.0000
451 INTENTIONAL OVERDOSE 2 0.0000
452 HIP FRACTURE 1 0.0000
453 HYPERHIDROSIS 4 0.0000
454 NIGHT SWEATS 1 0.0000
455 AMNESIA 2 0.0000
456 BLOOD CREATININE INCREASED 2 0.0000
457 IMPAIRED HEALING 1 0.0000
458 VISUAL ACUITY REDUCED 1 0.0000
459 BLOOD PRESSURE DECREASED 2 0.0000
460 SYNCOPE 3 0.0000
461 SKIN DISORDER 1 0.0000
462 ABDOMINAL DISCOMFORT 5 0.0000
463 TRANSIENT ISCHAEMIC ATTACK 1 0.0000
464 ILLNESS 3 0.0000
465 NAUSEA 23 0.0000
466 HEART RATE DECREASED 1 0.0000
467 RASH 12 0.0000
468 CRYING 1 0.0000
469 HYPOAESTHESIA 4 0.0000
470 DYSARTHRIA 1 0.0000
471 DISORIENTATION 1 0.0000
472 WEIGHT DECREASED 7 0.0000
473 HYPOTENSION 5 0.0000
474 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 5 0.0000
475 DYSKINESIA 1 0.0000
476 LUNG NEOPLASM MALIGNANT 1 0.0000
477 TREMOR 4 0.0000
478 ASTHENIA 9 0.0000
479 HYPOACUSIS 1 0.0000
480 SEPTIC SHOCK 1 0.0000
481 DEHYDRATION 3 0.0000
482 PULMONARY OEDEMA 1 0.0000
483 THROAT IRRITATION 1 0.0000
484 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 4 0.0000
485 UPPER RESPIRATORY TRACT INFECTION 1 0.0000
486 OROPHARYNGEAL PAIN 2 0.0000
487 ARRHYTHMIA 1 0.0000
488 PRODUCTIVE COUGH 1 0.0000
489 RASH ERYTHEMATOUS 1 0.0000
490 FEELING ABNORMAL 5 0.0000
491 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
492 CONTUSION 2 0.0000
493 HYPOGLYCAEMIA 1 0.0000
494 ATRIAL FIBRILLATION 2 0.0000
495 FLUID RETENTION 1 0.0000
496 SINUSITIS 2 0.0000
497 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1 0.0000
498 SPEECH DISORDER 1 0.0000
499 BRADYCARDIA 1 0.0000
500 TREATMENT NONCOMPLIANCE 1 0.0000
501 HAEMATOCHEZIA 1 0.0000
502 PAIN 11 0.0000
503 HYPONATRAEMIA 1 0.0000
504 BONE PAIN 1 0.0000
505 IRRITABILITY 1 0.0000
506 THERAPEUTIC RESPONSE DECREASED 1 0.0000
507 OEDEMA PERIPHERAL 2 0.0000
508 MUSCLE SPASMS 3 0.0000
509 FEELING HOT 1 0.0000
510 BLOOD GLUCOSE INCREASED 3 0.0000
511 GAIT DISTURBANCE 3 0.0000
512 INFUSION RELATED REACTION 1 0.0000
513 FALL 5 0.0000
514 DRY SKIN 2 0.0000
515 NEOPLASM MALIGNANT 1 0.0000
516 PRODUCT QUALITY ISSUE 2 0.0000
517 BURNING SENSATION 1 0.0000
518 SLEEP DISORDER 1 0.0000
519 THERAPY INTERRUPTED 1 0.0000
520 SKIN BURNING SENSATION 1 0.0000
521 BRONCHITIS 1 0.0000
522 INJECTION SITE SWELLING 1 0.0000
523 BACK PAIN 3 0.0000
524 VOMITING 6 0.0000
525 ARTHRITIS 1 0.0000
526 DRUG INTERACTION 2 0.0000
527 INJECTION SITE BRUISING 1 0.0000
528 CARDIAC FAILURE CONGESTIVE 1 0.0000
529 GASTROOESOPHAGEAL REFLUX DISEASE 1 0.0000
530 INFLUENZA LIKE ILLNESS 1 0.0000
531 URINARY TRACT INFECTION 2 0.0000
532 MUSCULOSKELETAL STIFFNESS 1 0.0000
533 COVID-19 2 0.0000
534 GASTROINTESTINAL DISORDER 1 0.0000
535 DEVICE ISSUE 1 0.0000
536 DIARRHOEA 7 0.0000
537 COUGH 3 0.0000
538 DYSPNOEA 6 0.0000
539 FATIGUE 8 0.0000
540 DYSPEPSIA 1 0.0000
541 FLUSHING 1 0.0000
542 ABDOMINAL PAIN UPPER 2 0.0000
543 ABDOMINAL DISTENSION 1 0.0000
544 CONSTIPATION 2 0.0000
545 THROMBOCYTOPENIA 1 0.0000
546 WEIGHT INCREASED 2 0.0000
547 RHEUMATOID ARTHRITIS 1 0.0000
548 DEPRESSION 2 0.0000
549 PYREXIA 3 0.0000
550 DECREASED APPETITE 2 0.0000
551 JOINT SWELLING 1 0.0000
552 LOSS OF CONSCIOUSNESS 1 0.0000
553 PERIPHERAL SWELLING 1 0.0000
554 CEREBROVASCULAR ACCIDENT 1 0.0000
555 MYALGIA 1 0.0000
556 MYOCARDIAL INFARCTION 1 0.0000
557 NASOPHARYNGITIS 1 0.0000
558 ANAEMIA 1 0.0000
559 ALOPECIA 1 0.0000
560 SOMNOLENCE 1 0.0000
561 ARTHRALGIA 2 0.0000
562 ABDOMINAL PAIN 1 0.0000
563 PRODUCT DOSE OMISSION ISSUE 1 0.0000
564 PAIN IN EXTREMITY 1 0.0000
565 DEATH 1 0.0000